Under the deal, Candid will have exclusive global rights to a tri-specific TCE discovered by WuXi using its WuXiBody platform. The Chinese company is set to receive an undisclosed upfront payment, as ...

The Hong Kong stock market has finished lower in four straight sessions, retreating more than 520 points or 2.8 percent along the ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: The Biopharmaceutical Contract ...

WuXi Biologics employees have once again exemplified their deep-rooted commitment to the local community, delivering ...

Role of Real-World Evidence (RWE) in Driving Pharmaceutical R&D Outsourcing Market Growth ...